Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.

Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.